Hims & Hers Health (NYSE:HIMS) announced its largest men's health expansion with new injectable and oral testosterone ...

In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $27.71, marking a -4.87% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.52%. At ...

Hims & Hers Health Inc. HIMS urged a court to throw out a consumer deception lawsuit, asserting that plaintiffs ignored clear ...

Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from ...

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) ( NYSE: ...

Hims & Hers Health slides 4.02% today to $27.95 after lawsuit news, with sellers persisting despite a long-term uptrend.

Hims & Hers Health trades at $29.13 today, down 0.21%. Legal risks from an FTC lawsuit could impact sentiment and volatility.

Hims & Hers Health, Inc. is currently listed on NYSE under HIMS. One share of HIMS stock can currently be purchased for approximately $28.01. Is Hims & Hers Health, Inc. listed on the NASDAQ or NYSE?

Hims argued that the agency ignored the company’s disclosures and misapplied federal law on subscriptions and privacy.

Hims & Hers Health ($HIMS) filed a motion on October 22 seeking dismissal of a federal lawsuit brought by the Federal Trade ...

MobiHealthNews spoke with healthcare stakeholders at the HIMSS AI Forum, who discussed topics ranging from how they use AI in ...

Well, have no fear, telehealth giant Hims is here to capitalize on…er, help address your feelings of inadequacy by offering testosterone replacement therapy service. The company announced Wednesday ...